• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Sweden·Healthcare·AMBEA.ST
Share

Ambea AB Stocks

SEK 140.2Last Updated 12.06.2026

Issuer Rating

6/7
Performance

Strong

Risk

Limited

Recommendation

Buy

Market Cap

SEK 1.19B

SEK 140.2
Key Takeaways

Risk factor

Low price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Ambea AB (publ) provides extensive health and social care provisions, encompassing accommodation, support services, educational offerings, and qualified personnel, to senior citizens and individuals with disabilities throughout Sweden, Norway, and Denmark. The company manages its operations through five primary divisions: Nytida, Vardaga, Stendi, Altiden, and Klara. The Nytida segment is dedicated to residential facilities, individual and family assistance, specialized educational institutions for children, adolescents, and adults with disabilities or psychosocial conditions, alongside various day services. Vardaga delivers care specifically for the elderly, featuring nursing homes, short-term residency options, in-home assistance, and day activity programs. Stendi addresses the needs of children, young people, and adults through personal assistance, residential living arrangements, elder care, and home-based support. The Altiden segment's portfolio includes services for the elderly, home care, general social care, and specialized disability support. Finally, Klara offers subscription-based services for mobile care teams and supplies temporary medical staff, such as physicians and nurses. Founded in 1996, Ambea AB (publ) maintains its head office in Solna, Sweden.

Company Valuation

Undervalued
6/7

Based on key historical and expected multiples, the stock is undervalued relative to its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITDA, under

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of AMBEA.ST is 182 and suggests 30% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

13.06.2026 03:02

Microsoft is considering spinning off Xbox into a separate company - The Information

13.06.2026 01:40

Hope for peace with Iran and SpaceX lifted spirits: stocks rose for second straight day

13.06.2026 01:05

SpaceX shares rose in value by 19% on the first day of trading. Is it worth buying them?

13.06.2026 01:04

SpaceX shares slowed before closing in first trading since record IPO

13.06.2026 00:44

Retail investors bought $15 billion worth of SpaceX stock. Demand was at least 6 times that amount

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026